|
Market Closed -
OTC Markets
13:36:00 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.000800 USD | 0.00% |
|
0.00% | +300.00% |
| 24-09-10 | Tyra Biosciences Names Doug Warner Chief Medical Officer | MT |
| 24-07-07 | EFFECTOR Therapeutics, Inc.(OTCPK:EFTR) dropped from S&P TMI Index | CI |
Company Valuation: eFFECTOR Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Market Cap 1 | 334.3 | 17.91 | 30.2 |
| Change | - | -94.64% | 68.61% |
| Enterprise Value (EV) 1 | 304.6 | 11.88 | 32.38 |
| Change | - | -96.1% | 172.45% |
| P/E | 18.8x | -0.78x | -0.71x |
| PBR | 19.3x | 4.58x | -6.01x |
| PEG | 0x | 0x | -0x |
| Capitalization / Revenue | 233,760,757x | 5,041,796x | - |
| EV / Revenue | - | - | - |
| EV / EBITDA | -9.56x | -0.37x | -0.96x |
| EV / EBIT | -9.55x | -0.37x | -0.96x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | 11 | -13.76 | -16.37 |
| Distribution rate | - | - | - |
| Net sales | 1.43 | 3.553 | - |
| EBITDA 1 | -31.87 | -32.35 | -33.73 |
| EBIT 1 | -31.9 | -32.4 | -33.84 |
| Net income 1 | 15.8 | -22.66 | -35.81 |
| Net Debt 1 | -29.67 | -6.029 | 2.175 |
| Reference price 2 | 207.000000 | 10.690000 | 11.685000 |
| Nbr of stocks (in thousands) | 1,615 | 1,676 | 2,585 |
| Announcement Date | 3/16/22 | 3/8/23 | 3/26/24 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 3.76K | ||
| 19.64x | 6.93x | 13.92x | 1.51% | 66.93B | ||
| 31.94x | 9.24x | 44.54x | 0.04% | 61.97B | ||
| -79.21x | 15.29x | -73.77x | -.--% | 28.26B | ||
| 28.46x | 6.03x | 15.64x | -.--% | 24.59B | ||
| -14.63x | 5.3x | -6.66x | -.--% | 24.3B | ||
| 26.45x | 4.98x | 16.56x | -.--% | 19.41B | ||
| 48.28x | 17.79x | 36.09x | 0.31% | 16.77B | ||
| 1225.47x | 35.26x | 769.42x | -.--% | 14.18B | ||
| -15x | 3382.33x | -17.29x | -.--% | 14B | ||
| Average | 141.27x | 387.02x | 88.72x | 0.21% | 27.04B | |
| Weighted average by Cap. | 73.54x | 184.88x | 49.64x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EFTR Stock
- Valuation eFFECTOR Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















